Takamatsu, H. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation. J. Clin. Med. 2017, 6, 91

. 2017 Nov 20;6(11):106. doi: 10.3390/jcm6110106

PMCID: PMC5704123 PMID: 29156604

The author wishes to make the following correction to this paper [1]:

In figure 3, the name “LymphoSIGHT^TM” should be replaced with “clonoSEQ^®”.

Reference

1.Takamatsu H. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation. J. Clin. Med. 2017;6:91. doi: 10.3390/jcm6100091. [DOI] [PMC free article] [PubMed] [Google Scholar]